Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Guided Modified Socket Shield With Hyaluronic Acid for Black Triangle Management

13 maggio 2026 aggiornato da: Walid Elamrousy, Kafrelsheikh University

Hyaluronic Acid With AI-Guided Immediate Implant Placement Using a Modified Socket Shield for Black Triangle Management: A Randomized Controlled Clinical Trial

The Primary aim of this study will be to evaluate the clinical, esthetic, and radiographic outcomes of hyaluronic acid combined with immediate implant placement using AI-assisted and computer guided modified socket shield technique in maxillary anterior sites exhibiting black triangles.

Panoramica dello studio

Descrizione dettagliata

The growing patient demand for quicker aesthetic solutions has led oral implantologists to adopt more immediate protocols compared to the delayed approach originally recommended by Brånemark. Studies have shown that implants placed immediately after atraumatic extraction can achieve success rates comparable to those placed in healed sockets. Other findings reported favorable results with immediate implant placement, including reduced resorptive bone changes post-extraction.

Following extraction, the alveolar ridge undergoes changes that often result in bone loss. This is mainly due to the elimination of periodontal ligament attachments and trauma during extraction, with the buccal bone plate being especially affected. Retaining part of the root has been shown to help preserve bone in pontic areas. In 2010, Hürzeler et al. introduced the socket shield technique to mitigate post-extraction bone loss by maintaining the labial portion of the root. Their results indicated stabilized buccal bone height.

Multiple modifications of the socket shield technique have since emerged. Modified socket shield technique (MSST), that involved thinning the labial shield to 1.5 mm, keeping it at the crest level, and leaving the space (jumping gap) between implant and shield without grafting . Some studies highlight the role of grafting this gap in achieving better outcomes. A histological investigation in sheep compared bone healing with and without grafting and found that although bone formed in both cases, the ungrafted bone was structurally weak and had fewer trabeculae, making it unsuitable for supporting masticatory loads.

Human histology showed that this gap could allow soft tissue ingrowth. Currently, there is no definitive human research proving the necessity of grafting in this context. Therefore, Gluckman emphasized the need for further clinical studies to evaluate the benefits of grafting the jumping gap in the MSST protocol.

Artificial intelligence (AI) has transformed digital planning and clinical execution in implant dentistry. AI-based tools analyze CBCT data, segment anatomical structures, identify vital landmarks, and simulate prosthetically driven implant positions with high accuracy. AI can improve implant positioning, angulation, depth control, and proximity to anatomical structures. It reduces surgical errors and improves long-term outcomes.

AI also enables precision in guide design and improves the predictability of immediate implant protocols. In esthetically demanding cases, such as those involving anterior maxillary implants, AI enhances decision-making and reduces clinician variability. It further allows prediction of soft and hard tissue changes through machine learning models trained on clinical imaging data.

In compromised situations, such as periodontally involved teeth, AI supports better planning by incorporating bone quality, defect morphology, and risk factors into surgical execution . It can detect critical patterns in bone loss, root anatomy, and soft tissue contours, guiding shield design and implant orientation.

Implant placement in sites previously affected by periodontitis poses risks. These sites often present with reduced bone volume, loss of papilla, apical migration of soft tissue, and compromised blood supply. Residual periodontal pathogens and altered healing responses make these areas less predictable for osseointegration.

Immediate implant placement in such sites requires careful evaluation. Inadequate primary stability and poor soft tissue support increase implant failure risk. Using guided protocols, with the support of AI and advanced techniques like root shielding, can help reduce complications. Maintaining remaining structures and optimizing healing are critical in these patients.

Reconstructing the interdental papilla remains one of the most demanding aesthetic challenges in periodontology. The interdental papilla contributes not only to appearance but also to function. It also plays a protective role for the periodontium by preventing debris accumulation. Black triangles may develop. These can result from aging, tooth shape, or periodontal conditions.

Over the years, several surgical strategies, such as coronally advanced flaps or subepithelial connective tissue grafts, have been proposed. These interventions often yield inconsistent outcomes due to limited blood flow and the small size of the papillary area. ] Recently, non-surgical techniques have gained attention for papilla reconstruction. These include prosthetic adjustments, restorative procedures, and orthodontic interventions. One minimally invasive option is the injection of hyaluronic acid gel (HA) to restore lost interdental papilla between teeth or implants. This approach is considered safe and shows promising outcomes. HA is a naturally found linear polysaccharide in the extracellular matrix and exists in gingival tissues and the periodontal ligament. Its clinical effect usually lasts between 6 and 12 months.

Due to its hygroscopic properties, HA contributes to lubrication, volume maintenance, protein exclusion, and shock absorption in papillary gaps. It also supports wound healing, tissue repair, and the structural balance of periodontal tissues.

As far as the authors are aware, this is the first study utilizing socket shield approach in periodontally compromised sites & the first study that combines AI assisted and computer guided socket shield with HA in periodontally compromised sites in anterior esthetic zone.

Tipo di studio

Interventistico

Iscrizione (Stimato)

32

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Kafrelsheikh
      • Kafr ash Shaykh, Kafrelsheikh, Egitto, 214312
        • faculty of dentistry, kafrelsheikh University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Descrizione

Inclusion Criteria:

  • Adults (20-50) years old.
  • Single rooted maxillary anterior teeth with hopeless prognosis.
  • Periodontally compromised but with >50% remaining bone.
  • Presence of black triangle ≥2 mm.
  • Systemically healthy.

Exclusion Criteria:

  • Medically compromised patients and systemic conditions that complicate implant placement as uncontrolled diabetes, osteoporosis.
  • Alcoholic and Smokers patients.
  • Pregnant or lactating women.
  • Acute Pathology or infection at implant site
  • Patients with a history of chemotherapy, radiotherapy in head and/or neck region.
  • Patients on bisphosphonate or steroids therapy.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Flapless Socket shield technique with AI-based immediate implant placement
The root was vertically sectioned with removal of the palatal fragment and preservation of a 2 mm buccal shield shaped and beveled to support the emergence profile. Guided osteotomy was performed followed by immediate implant placement
Computer guided socket shield with immediate implant placement
Sperimentale: Flapless Socket shield technique with AI-based immediate implant placement & Hyaluronic Acid
The root was vertically sectioned with removal of the palatal fragment and preservation of a 2 mm buccal shield shaped and beveled to support the emergence profile. Guided osteotomy was performed followed by immediate implant placement then 0.2 mL of hyaluronic acid was injected into the interproximal papillary area
Computer guided socket shield with immediate implant placement with papilla injection by 0.2 mL of hyaluronic acid

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Interproximal papilla fill
Lasso di tempo: 12-months
Using digital photographs the fill of interdental papilla will be assessed
12-months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
pink esthetic score
Lasso di tempo: 12-months
The Pink Esthetic Score (range: 0-14) was assessed based on digital intraoral photographs by assigning a score of 0 to 2 for the following criteria compared to the adjacent reference tooth: mesial and distal papillae, soft tissue color, texture, level, contour, and alveolar bone defect
12-months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Cattedra di studio: Ahmed abdelmonem, bachelor, Faculty of Dentistry, Tanta University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

10 maggio 2026

Completamento primario (Stimato)

10 giugno 2027

Completamento dello studio (Stimato)

15 giugno 2027

Date di iscrizione allo studio

Primo inviato

8 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

8 maggio 2026

Primo Inserito (Effettivo)

14 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • OMPDR4-26/3575

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Impianto dentale fallito

Sottoscrivi